Comparative Review of Oral P2Y12 Inhibitors.

about

Comparative Review of Oral P2Y12 Inhibitors.

Item

http://www.wikidata.org/entity/Q55396201

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Comparative Review of Oral P2Y12 Inhibitors.

@en

Comparative Review of Oral P2Y12 Inhibitors.

@nl

type

Item

label

Comparative Review of Oral P2Y12 Inhibitors.

@en

Comparative Review of Oral P2Y12 Inhibitors.

@nl

prefLabel

Comparative Review of Oral P2Y12 Inhibitors.

@en

Comparative Review of Oral P2Y12 Inhibitors.

@nl

P1476

Comparative Review of Oral P2Y12 Inhibitors.

@en

P2093

Blake Kennedy

http://www.w3.org/2001/XMLSchema#string

Renee Koski

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials.

Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry.

P304

352-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29896034

http://www.w3.org/2001/XMLSchema#string

P932

5969212

http://www.w3.org/2001/XMLSchema#string